Table 2 Multivariate logistic regression analysis of factors correlated with symptoms of depression in HIV + respondents on ARV treatment

District (comparison group = Lejweleputswa)

Motheo

0.91

0.42 - 1.98

Fezile Dabi

0.84

0.37 - 1.89

Thabo Mofutsanyane

1.08

0.54 - 2.14

Xhariep

0.41

0.04 - 3.90

Female

0.93

0.50 - 1.72

Age (comparison group = under 30)

30-34 years

1.21

0.54 - 2.70

35-39 years

1.72

0.76 - 3.87

40-44 years

1.68

0.73 - 3.89

45+ years

2.30

0.93 - 5.67

Marital status (comparison group = single)

Cohabiting

0.75

0.38 - 1.48

Not cohabiting

0.64

0.26 - 1.59

Widowed

0.30

*

0.13 - 0.69

Separated or divorced

0.89

0.40 - 1.99

Education (comparison group = none)

Primary

1.87

0.44 - 7.99

Some secondary

1.24

0.29 - 5.34

Matric and post-matric

1.11

0.23 - 5.30

Dwelling (comparison group = formal dwelling)

Informal

0.82

0.39 - 1.74

Traditional

1.11

0.48 - 2.55

Other

0.92

0.39 - 2.15

Treatment buddy (yes/no)

1.20

0.88 - 1.64

Community worker (yes/no)

0.91

0.30 - 2.71

Support group (yes/no)

0.21

*

0.05 - 0.99

Positive coping

0.68

0.44 - 1.06

Avoidant coping

1.01

0.98 - 1.04

Seeking social-support group

1.05

0.75 - 1.49

Stigma scale

1.13

**

1.06 - 1.20

Disclosure (comparison group = none)

Disclosed to some

0.43

0.09 - 2.08

Disclosed to all

1.18

0.29 - 4.90

Drink alcohol (yes/no)

0.83

0.38 - 1.79

Smoke tobacco (yes/no)

1.61

0.66 - 3.93

Smoke dagga (yes/no)

0.39

0.10 - 1.50

Sexual activity (comparison group = no sex)

Always use a condom

0.90

0.53 - 1.51

Inconsistent condom use

1.12

0.45 - 2.77

Never use a condom

0.93

0.20 - 4.35

Financial status (comparison group = disability grant)

Old-age pension

0.64

0.19 - 2.14

Child grant

1.47

0.31 - 7.01

Employed

0.74

0.37 - 1.49

Support within the household

0.73

0.36 - 1.49

Support outside the household

1.11

0.44 - 2.78

Other

0.68

0.26 - 1.78

Food supplements (comparison group = never)

Previously

0.56

0.18 - 1.76

Currently

0.32

0.10 - 1.00

Time since first HIV + test

1.02

**

1.01 - 1.03

Side effects (comparison group = no side effects)

Somewhat disruptive side effects

1.05

0.54 - 2.05

Very disruptive side effects

1.79

0.92 - 3.46

Health-related quality of life (EQ-VAS)

0.99

0.97 - 1.00

Sample size

499

Wald-statistic

82.26

P-value

< 0.001

R 2

0.17

% successfully predicted

78.96